Cipla and Strides Sign Pact With MMV: Fight Against Malaria

by Vani Pradeep on  November 28, 2014 at 6:53 PM Child Health News
RSS Email Print This Page Comment bookmark
Font : A-A+

In collaboration with MMV, based in Switzerland, Cipla and Strides Arcolab venture to develop rectal artesunate for pre-referral malaria treatment severe in children.
 Cipla and Strides Sign Pact With MMV: Fight Against Malaria
Cipla and Strides Sign Pact With MMV: Fight Against Malaria

The MMV-led project is UNITAID funded and intend to submit a rectal artesunate product to WHO World Health Organisation. A 5.6 million cases have been estimated for severe malaria every year and results to 627,000 deaths and it includes mostly children under five years.

"We have agreed a clear pathway with these two manufacturers to bring this product to an internationally acceptable quality standard. This will help make the product available to more patients, buying more time and saving more lives," MMV CEO David Reddy said.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Malaria-water Malaria Mosquito Diseases Fever 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...